A US federal appeals court has reinstated private lawsuits claiming that use of Tylenol during pregnancy is linked to autism and ADHD in children, according to CNBC, which reports there is no firm scientific evidence supporting such a link.
Key facts
- A US appeals court has revived private lawsuits linking Tylenol to autism, according to CNBC.
- The suits allege a connection between Tylenol use during pregnancy and autism and ADHD in children.
- There is no firm scientific evidence establishing such a link, according to CNBC.
- The decision was reported by CNBC on 13 July 2026.
A US federal appeals court has revived private lawsuits that allege a link between the use of Tylenol during pregnancy and the development of autism and attention-deficit hyperactivity disorder (ADHD) in children, according to CNBC.
CNBC reports that there is no firm scientific evidence linking Tylenol use during pregnancy to autism and ADHD in children.
Further details of the appeals court’s ruling, including its reasoning and next steps in the litigation, were not specified in the available reporting.
Why it matters
Tylenol is a widely used over-the-counter pain reliever, and litigation over its safety during pregnancy draws attention to the gap between the allegations in these lawsuits and the current scientific evidence, which CNBC reports has not established such a link.
Frequently asked questions
What do the lawsuits claim?
The private lawsuits allege a link between the use of Tylenol during pregnancy and autism and attention-deficit hyperactivity disorder (ADHD) in children, according to CNBC.
Is there scientific evidence linking Tylenol to autism?
According to CNBC, there is no firm scientific evidence linking Tylenol use during pregnancy to autism and ADHD in children.
What did the appeals court decide?
The U.S. appeals court revived the private lawsuits, allowing the claims to move forward, as reported by CNBC on July 13, 2026.